Sponsored
by WuXi AppTec
Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
22/09/2021 - 7 minutes
Alzheimer’s
AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
02/09/2021 - 5 minutes
Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene
Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month.…
20/07/2021 - 4 minutes
Scotland’s Top 10 Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
30/06/2021 - 11 minutes
FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space
The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last…
17/06/2021 - 6 minutes
Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
21/12/2020 - 5 minutes
An Alzheimer’s Vaccine Challenged the Consensus for 25 Years
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
02/09/2020 - 8 minutes
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
09/04/2020 - 4 minutes
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
24/03/2020 - 3 minutes
EU Project Set up to Fight Alzheimer’s Disease with Lasers
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
07/02/2020 - 3 minutes
German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround
The German company Vivoryon Therapeutics has raised €43M on Euronext Amsterdam to fund a phase…
24/10/2019 - 2 minutes
AC Immune Gets €28M from Eli Lilly as Alzheimer’s Drug Hits Phase I
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
23/09/2019 - 2 minutes
